Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.47 USD | -1.26% |
|
-1.97% | -28.57% |
05-30 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
05-20 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.57% | 1.99B | |
+25.28% | 89.17B | |
-22.97% | 75.87B | |
+2.32% | 27.41B | |
-10.43% | 17.52B | |
-0.32% | 17.04B | |
+0.31% | 15.36B | |
+77.32% | 13.67B | |
+78.47% | 13.18B | |
-25.61% | 12.83B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group Adjusted Earnings, Revenue Rise in Q1; Offers Full Year 2024 Revenue Guidance